Steroid sulfatase in breast carcinoma and change of serum estrogens levels after operation

References

• Liton A, Santner S, Santen RJ, et al. Aromatase activity in primary and metastatic human breast cancer. Cancer 1987; 59: 779–82
   PubMedGoogle Scholar
• Pasqualini JR, Chetrite GS. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J Steroid Biochem Mol Biol 2005; 93: 221–36
   PubMed Web of Science ®Google Scholar
• Pasqualini JR, Chetrite G, Blacker C, et al. Concentrations of estrone, estradiol and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and post-menopausal breast cancer patients. J Clin Endocrinol Metab 1996; 81: 1460–4
   PubMed Web of Science ®Google Scholar
• Wilking K, Carlstrom K, Gustafsson SA, et al. Oestrogen receptors and metabolism of oestrone sulfate in human mammary carcinoma. Eur J Cancer 1980; 16: 1339–44
   PubMed Web of Science ®Google Scholar
• Vignon F, Tergui M, Westley B, et al. Effect of plasma estrogen sulfates in mammary cancer cells. Endocrinology 1980; 106: 1079–86
   PubMed Web of Science ®Google Scholar
• Howell A, Cuzick J, Baum M, et al. Results of ATAC (‘Arimidex’, tamoxifen, alone or in combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 2005; 365: 60–2
   PubMed Web of Science ®Google Scholar
• Morris KT, Toth-Fejel S, Schmidt J, Fletcher WS, Pommier RF. High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: A renewed role for adrenalectomy. Surgery 2001; 130: 947–53
   PubMed Web of Science ®Google Scholar
• Utsumi T, Yoshimura N, Takeuchi S, et al. Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer. Cancer Res 1999; 59: 377–81
   PubMed Web of Science ®Google Scholar
• Suzuki T, Nakata T, Miki Y, et al. Estrogen sulfotransferase and steroid sulfatase in human breast carcinoma. Cancer Res 2003; 63: 2762–70
   PubMed Web of Science ®Google Scholar
• Yanaihara Y, Yanaihara T, Toma Y, et al. Localization and expression of steroid sulfatase in human fallopian tubes. Steroid 2001; 66: 87–91
   PubMedGoogle Scholar
• Osawa Y, Higashiyama T, Yarborough C, Shimizu Y, Yanaihara T.. Purification of human estrogen sulfatase and monoclonal antibody preparation. 81^st Annual Meeting of The Endocrine Society 1999; Abstr.
   Google Scholar
• Suzuki T, Hirato K, Yanaihara T, et al. Purification and properties of steroid sulfatase from human placenta. Endocrinol Jpn 1992; 39: 93–101
   PubMedGoogle Scholar
• Evans TR, Rowiands MG, Law M, Coombes RC. Intratumoral oestrone sulphatase activity as a prognostic marker in human breast carcinoma. Br J Cancer 1994; 69: 555–61
   PubMedGoogle Scholar
• Kurosumi M. Significance of immunohistochemical assessment of steroid hormone receptor status for breast cancer patients. Breast Cancer 2003; 10: 97–104
   PubMedGoogle Scholar
• Gelly C, Sumida C, Gulino A, Pasqualini JR. Concentration of estradiol and estrone in plasma, uterus and other tissues of fetal guinea-pigs: Their relationship to uptake and specific binding of [3H]-estradiol. J Endocr 1981; 89: 71–7
   PubMedGoogle Scholar
• Pasqualini JR, Gelly C, Lecerf F. Estrogen sulfates: Biological and ultrastructural responses and metabolism in MCF-7 human breast cancer cells. Breast Cancer Res Treat 1986; 8: 233–40
   PubMedGoogle Scholar
• Speirs V, Walton DS, Hall M-C, Atkin SL. In vivo and in vitro expression of steroid-converting enzymes in human breast tumors; associations with interleukin-6. Br J Cancer 1999; 81: 690–5
   PubMed Web of Science ®Google Scholar
• Yoshimura N, Harada N, Bukholm, et al. Intratumoral mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer. Breast Cancer Res 2004; 6: 46–55
   Google Scholar
• Reed MJ, Purohit A. Breast cancer and the role of cytokines in regulating estrogen synthesis: An emerging hypothesis. Endo Rev 1997; 18: 701–5
   PubMed Web of Science ®Google Scholar
• Santner SJ, Feil PD, Santen RJ. In situ estrogen production via the estrone sulfatase pathway in breast tumors: Relative importance versus the aromatase pathway. J Clin Endo Metab 1984; 59: 29–33
   PubMed Web of Science ®Google Scholar
• Tsunoda Y, Kamiya K, Tsunoda A, et al. Immunohistochemical detection of aromatase in breast carcinomas. Showa Univ J Med Sci 2000; 12: 247–52
   Google Scholar
• Ruder HJ, Loriaux L, Lipsett MB. Estrone sulfate: Production rate and metabolism in man. J Clin Invest 1972; 51: 1020–33
   PubMed Web of Science ®Google Scholar
• Prost O, Turrel M, Dahan N, et al. Estrone and dehydroepiandrosterone sulfatase activities and plasma estrone sulfate levels in human breast carcinoma. Cancer Res 1984; 44: 661–4
   PubMedGoogle Scholar
• Chetrite GS, Cortes-Prieto J, Philippe JC, Wright F, Pasqualini JR. Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. J Steroid Biochem Molec Biol 2000; 72: 23–7
   PubMed Web of Science ®Google Scholar
• Lloyd MD, Thiyagarajan N, Ho YT, et al. First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitors. Biochemistry 2005; 44: 6858–66
   PubMed Web of Science ®Google Scholar